glp-1 management platforms startups Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Therapies Evolve with Multi-Hormone

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Personalized dosing, sideeffect coaching, and offramp planning.

Currently, there is no approved treatment for NAFLD and NASH

Backed by Science Cited in 1,500+ scientific publications, Akkermansia muciniphila is recognized as a promising probiotic in reviews from Microbial Biotechnology (PMC6801136), Journal of Applied Microbiology (OUP, 130:6, 1813-1830), Gut Microbes (PMC11364076), and Frontiers in Microbiology (Front Microbiol, 2024) for

More than 2% of Kentuckians use the drugs which mimic a hormone that triggers the release of insulin.

Not approved for human or veterinary use.